European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts)

Eur Heart J. 2012 Jul;33(13):1635-701. doi: 10.1093/eurheartj/ehs092. Epub 2012 May 3.
No abstract available

Publication types

  • Practice Guideline

MeSH terms

  • Adult
  • Aged
  • Antihypertensive Agents / therapeutic use
  • Biomarkers
  • Blood Pressure / physiology
  • Cardiology
  • Cardiovascular Agents / therapeutic use
  • Cardiovascular Diseases / prevention & control*
  • Chronic Disease / prevention & control
  • Delivery of Health Care
  • Diabetes Mellitus, Type 2 / prevention & control
  • Diabetic Angiopathies / prevention & control
  • Diagnostic Imaging
  • Diet
  • Drug Combinations
  • Early Diagnosis
  • Electronic Health Records
  • Evidence-Based Medicine
  • Exercise / physiology
  • Female
  • General Practice
  • Health Promotion
  • Hospitalization
  • Humans
  • Hypercholesterolemia / complications
  • Hypercholesterolemia / prevention & control
  • Hypertension / complications
  • Hypertension / prevention & control
  • Life Style
  • Lipids / blood
  • Male
  • Medication Adherence
  • Middle Aged
  • Nurse's Role
  • Obesity / complications
  • Obesity / prevention & control
  • Patient Selection
  • Physician's Role
  • Primary Health Care / organization & administration
  • Prognosis
  • Risk Assessment
  • Risk Reduction Behavior
  • Self Care
  • Smoking / adverse effects
  • Smoking Cessation / methods
  • Smoking Prevention
  • Socioeconomic Factors
  • Stress, Psychological / complications
  • Stress, Psychological / prevention & control

Substances

  • Antihypertensive Agents
  • Biomarkers
  • Cardiovascular Agents
  • Drug Combinations
  • Lipids